BETHESDA, Md.-- (BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) today announced that the Company received a supplement approval from the U.S. Food and Drug Administration (FDA) that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results